Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Nordnet in connection with the takeover bid from the Öhman Group and Nordic Capital
Mandate

Vinge advises Nordnet in connection with the takeover bid from the Öhman Group and Nordic Capital

October 25, 2016

The Öhman Group, the main owner of Nordnet, and Nordic Capital have, through NNB Intressenter AB, made a public offer to the shareholders of Nordnet AB (publ) (Nasdaq Stockholm). The Offer values all shares of Nordnet at SEK 6,476 million.
 
Vinge advises Nordnet. The Vinge team is headed by capital markets and public M&A partner Erik Sjöman and includes Malte Hedlund, Pernilla Warg and Christoffer Widström.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026